OGM & NGS – The Future of Clinical Genomics
Post# of 79
(Total Views: 69)
Posted On: 07/12/2025 7:09:59 AM
OGM & NGS – The Future of Clinical Genomics
The future of genomic diagnostics is here, and it’s all about Optical Genome Mapping (OGM) and Next-Generation Sequencing (NGS). Together, they’re replacing outdated methods like karyotyping, microarrays, and FISH with a faster, more accurate workflow.
OGM reveals the structural blueprint of the genome, catching large variants that sequencing misses and NGS delivers the fine details, spotting single-base changes with precision.
Integrated platforms now combine both in one streamlined view, boosting diagnostic yield, cutting turnaround time, and simplifying lab operations.
This isn’t just evolution, it’s a complete shift in how labs deliver answers. Investors should pay attention: OGM and NGS are becoming the new foundation of clinical genomics, leaving legacy methods behind. The companies enabling this transition are shaping the future of precision medicine.
INVESTORS SHOULD PAY ATTENTION!
The future of genomic diagnostics is here, and it’s all about Optical Genome Mapping (OGM) and Next-Generation Sequencing (NGS). Together, they’re replacing outdated methods like karyotyping, microarrays, and FISH with a faster, more accurate workflow.
OGM reveals the structural blueprint of the genome, catching large variants that sequencing misses and NGS delivers the fine details, spotting single-base changes with precision.
Integrated platforms now combine both in one streamlined view, boosting diagnostic yield, cutting turnaround time, and simplifying lab operations.
This isn’t just evolution, it’s a complete shift in how labs deliver answers. Investors should pay attention: OGM and NGS are becoming the new foundation of clinical genomics, leaving legacy methods behind. The companies enabling this transition are shaping the future of precision medicine.
INVESTORS SHOULD PAY ATTENTION!
(0)
(0)